About
Small Molecules, Generics
Areas of Focus
Categories
Small Molecule PharmaceuticalGeneric DrugJapan
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
61
By Phase
PHASE1: 2PHASE1/PHASE2: 2
By Status
COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04688034Collaborator
Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.
PHASE1Completed
5 participants
Started: Mar 15, 2021 · Completed: Jul 5, 2022
NCT04546074Collaborator
Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
PHASE1/PHASE2Recruiting
22 participants
Started: Sep 14, 2020 · Completed: Oct 31, 2025
NCT04047160Collaborator
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
PHASE1Completed
7 participants
Started: Aug 29, 2019 · Completed: Mar 31, 2022
NCT03620474Collaborator
Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis
PHASE1/PHASE2Completed
27 participants
Started: Jul 24, 2018 · Completed: Feb 28, 2022
Locations (1)
Headquarters
Shiga, Japan
Map
Loading map...